Lexology August 12, 2024
Megan Browdie, Kathy O’Neill, Anna Caro and Amanda Griggs, Cooley LLP
This is an extract from the 2025 edition of the Americas Antitrust Review published by Global Competition Review. The whole publication is available here.
This is an Insight article, written by a selected partner as part of GCR’s co-published content. Read more on Insight
In summary
The technology and life sciences industries continue to be front of mind at the US Department of Justice and the Federal Trade Commission and the focus of significant enforcement efforts. Armed with the recently released merger guidelines, and no guarantee of a second term, Biden antitrust enforcers are swinging for the fences in 2024 with an aggressive approach to merger enforcement that will...